Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Equity Ratio (2019 - 2026)

Alx Oncology Holdings' Equity Ratio history spans 5 years, with the latest figure at 0.78 for Q4 2023.

  • On a quarterly basis, Equity Ratio fell 9.01% to 0.78 in Q4 2023 year-over-year; TTM through Dec 2023 was 0.78, a 9.01% decrease, with the full-year FY2023 number at 0.78, down 9.01% from a year prior.
  • Equity Ratio hit 0.78 in Q4 2023 for Alx Oncology Holdings, up from 0.77 in the prior quarter.
  • Over the last five years, Equity Ratio for ALXO hit a ceiling of 0.99 in Q4 2020 and a floor of 6.62 in Q4 2019.
  • Historically, Equity Ratio has averaged 0.33 across 5 years, with a median of 0.91 in 2022.
  • Biggest five-year swings in Equity Ratio: surged 217.45% in 2021 and later decreased 15.12% in 2023.
  • Tracing ALXO's Equity Ratio over 5 years: stood at 6.62 in 2019, then surged by 114.9% to 0.99 in 2020, then decreased by 3.13% to 0.95 in 2021, then dropped by 9.98% to 0.86 in 2022, then dropped by 9.01% to 0.78 in 2023.
  • Business Quant data shows Equity Ratio for ALXO at 0.78 in Q4 2023, 0.77 in Q3 2023, and 0.86 in Q2 2023.